Globally, the prevalence of inflammatory bowel disorder has been increasing, mainly due to several risk factors such as high pollution due to rapid establishment of industries, smoking and habitual use of non-steroidal anti-inflammatory medicines. The inflammatory bowel disorder therapeutic pipeline is expected to grow in the future mainly due to the emergence of several novel drugs in the market, since various pharmaceutical and biotechnology companies have been focusing to develop drugs for the treatment of this disease. According to the Centers for Disease Control and Prevention (CDC), approximately 1 to 1.3 million population suffers from inflammatory bowel disorder, in the U.S.
Inflammatory bowel disorder is a condition in which patients feel chronic inflammation in all the parts of digestive tract. Inflammatory bowel disorder is very painful condition and may persist for a long time. Inflammatory bowel disorder primarily involves Crohn’s disease and ulcerative colitis, both these diseases are a type of inflammatory bowel syndrome. Ulcerative colitis mainly affects the large intestine (colon) whereas Crohn’s disease can affect any part of the digestive system, from the mouth to the anus. There are various symptoms which are associated with inflammatory bowel syndrome and some of them includes abdominal pain, weight loss, loss of appetite, fever, diarrhea, vomiting, anemia, and constipation.
Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/inflammatory-bowel-disorder-therapeutics-pipeline-analysis/toc-sample
Some of the companies having a pipeline of inflammatory bowel disorder therapeutics pipeline include Protagonist Therapeutics, Eli Lilly & Company, Arena Pharmaceuticals, Fast forward Pharmaceuticals, Jansen-Cilag Ltd, Redhill Biopharma Ltd, Kyowa Kirin Pharmaceutical Development, Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)